trending Market Intelligence /marketintelligence/en/news-insights/trending/5JLtUnwF7Lu2eAwzB6ac4A2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Meridian Bioscience acquires Quebec-based GenePOC


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Meridian Bioscience acquires Quebec-based GenePOC

Cincinnati-based Meridian Bioscience Inc. completed its planned acquisition of GenePOC Inc., a Quebec-based manufacturer of molecular diagnostic instruments and assays.

The company entered into a deal of up to $120 million with GenePOC in late April, with $50 million cash payable at closing and additional future payments of up to $70 million on achieving certain milestones.

Meridian was targeting to complete the transaction by early fourth quarter of 2019.